APA (7th ed.) Citation

T, W., K, O., & SC, P. (2026). Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease. American journal of ophthalmology, 284, 216. https://doi.org/10.1016/j.ajo.2026.01.009

Chicago Style (17th ed.) Citation

T, Wada, Omatsu K, and Pflugfelder SC. "Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease." American Journal of Ophthalmology 284 (2026): 216. https://doi.org/10.1016/j.ajo.2026.01.009.

MLA (9th ed.) Citation

T, Wada, et al. "Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease." American Journal of Ophthalmology, vol. 284, 2026, p. 216, https://doi.org/10.1016/j.ajo.2026.01.009.